Oramed Pharmaceuticals, Inc. (ORMP)
3.36
+0.02
(+0.60%)
USD |
NASDAQ |
Mar 03, 16:00
3.36
0.00 (0.00%)
After-Hours: 19:10
Oramed Pharmaceuticals EPS Diluted (Quarterly) : 1.131 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifeward Ltd. | -2.374 |
| Bristol Myers Squibb Co. | 0.5326 |
| Merck & Co., Inc. | 1.191 |
| Instil Bio, Inc. | -2.011 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 48.39M |
| Total Expenses (Quarterly) | -48.40M |
| Enterprise Value | -1.839M |
| Earnings Yield | 29.84% |
| Normalized Earnings Yield | 16.63 |